4D-150 Phase III wet AMD trials fully enrolled; data due next year
4D-150 Phase III trials in wet AMD are fully enrolled. Major data readouts are expected next year for the therapy aimed at reducing treatment burden and preserving vision.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.